Lead Product(s): NPI-001
Therapeutic Area: Ophthalmology Product Name: NPI-001
Highest Development Status: Phase I Product Type: Undisclosed
Partner/Sponsor/Collaborator: Nacuity Pharmaceuticals
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement March 31, 2021
Nanoform and Nacuity have signed a Technology Proof of Concept Agreement. This will apply Nanoform’s award-winning nanoparticle CESS technology to enhance ophthalmic drug delivery of Nacuity’s NPI-001 and NPI-002 drug candidates.